Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.

Abstract

Although the primary study endpoint was not achieved, the overall observed response pattern suggests the efficacy of duloxetine in the treatment of Chinese patients with diabetic peripheral neuropathic pain. The safety profile for duloxetine is similar to that reported in other global trials.